谷歌浏览器插件
订阅小程序
在清言上使用

MPN-274 Avapritinib in Patients with Advanced Systemic Mastocytosis (advsm): Efficacy and Safety Analysis from the Phase 2 PATHFINDER Study with 3-Year Follow-up

Clinical Lymphoma Myeloma and Leukemia(2024)

引用 0|浏览10
关键词
MPN,systemic mastocytosis,tyrosine kinase inhibitor,c-kit
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要